Table 3.

Decision making in patients with hepatocellular carcinoma with Child–Pugh class A status with a single tumour according to the Barcelona Clinic Liver Cancer algorithm and liver stiffness values

Patient	Child–Pugh class	Bilirubin	MELD score	PST	Okuda stage	PHa	Liver stiffness	AD	Treatment
1	A	<2.0	<10	0	I	No	Low–moderate	No	Resection
2	A	<2.0	<10	0	I	No	Low–moderate	No	Resection
3	A	<2.0	<10	0	I	2	Low–moderate	No	Resection
4	A	<2.0	<10	0	I	1	Low–moderate	Diabetes	Resection
5	A	<2.0	<10	1	I	No	Low–moderate	No	Resection
6	A	<2.0	<10	1	I	No	Low–moderate	No	Resection
7	A	2.2	<10	1	I	2	Low–moderate	No	Resection
8	A	<2.0	<10	0	I	3	Low–moderate	No	Resection
9	A	2.0	<10	0	I	1	High	CVD	PEI
10	A	3.0	<10	1	I	2	High	CVD	PEI
11	A	3.0	<10	1	I	2	High	Diabetes, CVD	RFA
12	A	2.6	<10	0	I	1	High	No	RFA
13	A	2.5	<10	1	I	3	High	Diabetes	PEI
14	A	2.5	<10	0	I	2	High	No	RFA
15	A	<2.0	<10	0	I	2	High	No	RFA
16	A	<2.0	<10	1	I	2	High	Diabetes	RFA
17	A	<2.0	<10	2	I	3	High	COPD	RFA
18	A	2.4	<10	1	I	2	High	CVD	RFA
19	A	<2.0	<10	2	I	2	High	COPD	RFA
20	A	2.3	<10	1	I	2	High	Diabetes	RFA

^a1 = oesophageal varices (OV); 2 = OV + splenomegaly (S); 3 = OV + S + platelet count of <100 000 platelets/mm³.

AD, associated diseases; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; MELD, Model for End-stage Liver Disease; PEI, percutaneous ethanol injection; RFA, radiofrequency ablation; PH, portal hypertension; PST, performance status test.